How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs

Bioequivalence for Generic Topical and Transdermal (6of35) Complex Generics– Sep. 25-26, 2019Подробнее

A New Possible Way to Evaluate Bioequivalence of Topical DrugsПодробнее

PBPK to Guide Study Design and Product Development for Generic Dermatological ProductsПодробнее

Complex Generics: Topical Products, Part 1Подробнее

In Vitro Release Testing for Complex Generics: A Bioequivalence PerspectiveПодробнее

PBPK Modeling for BE in Dermatological Products (24of39) Complex Generics 2018Подробнее

Achieving Virtual Bioequivalence with PBPK in Lieu of Clinical StudiesПодробнее

In vitro bioequivalence testing for topical ophthalmic suspension products (17of39) Complex GenericsПодробнее

In Vivo Dermal Microperfusion & Microdialysis Bioequivalence ApproachesПодробнее

Leveraging Dermal PBPK Modeling and Simulation ApproachesПодробнее

In Vitro Bioequivalence Testing of Topical Generic ProductsПодробнее

PBPK modelling of in vitro skin permeation & IVIVE for topically applied metronidazoleПодробнее

Explaining Bioequivalence: Making the Complex Understandable in Pharma CasesПодробнее

Assessment of Complex Drug Product – Physicochemical Characteristics to Support In Vitro BE StudiesПодробнее

Model-Integrated Evidence for Generic Drug Development – Session 1BПодробнее

Non-Invasive Raman Spectroscopy-Based Bioequivalence ApproachesПодробнее

Practical Considerations for Bioequivalence of GI Locally-Acting ProductsПодробнее

Strategies for Generic Topical Product Development (7of35) Complex Generics– Sep. 25-26, 2019Подробнее

Topical Dosage Forms: Emerging Insights and Implications for Bioequivalence ApproachesПодробнее